- Home
- WKC vs BCRX Comparison
WKC vs BCRX Comparison
Compare WKC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- BCRX
- Stock Information
- Founded
- WKC 1984
- BCRX 1986
- Country
- WKC United States
- BCRX United States
- Employees
- WKC N/A
- BCRX N/A
- Industry
- WKC Oil Refining/Marketing
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WKC Energy
- BCRX Health Care
- Exchange
- WKC Nasdaq
- BCRX Nasdaq
- Market Cap
- WKC 1.6B
- BCRX 1.7B
- IPO Year
- WKC N/A
- BCRX 1994
- Fundamental
- Price
- WKC $28.41
- BCRX $9.19
- Analyst Decision
- WKC Sell
- BCRX Buy
- Analyst Count
- WKC 4
- BCRX 9
- Target Price
- WKC $29.00
- BCRX $16.89
- AVG Volume (30 Days)
- WKC 622.0K
- BCRX 3.6M
- Earning Date
- WKC 07-24-2025
- BCRX 08-04-2025
- Dividend Yield
- WKC 2.81%
- BCRX N/A
- EPS Growth
- WKC N/A
- BCRX N/A
- EPS
- WKC 0.32
- BCRX N/A
- Revenue
- WKC $40,669,100,000.00
- BCRX $503,485,000.00
- Revenue This Year
- WKC N/A
- BCRX $39.04
- Revenue Next Year
- WKC $3.88
- BCRX $13.26
- P/E Ratio
- WKC $87.65
- BCRX N/A
- Revenue Growth
- WKC N/A
- BCRX 41.67
- 52 Week Low
- WKC $22.71
- BCRX $6.02
- 52 Week High
- WKC $31.71
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- WKC 57.10
- BCRX 34.12
- Support Level
- WKC $27.13
- BCRX $9.19
- Resistance Level
- WKC $28.43
- BCRX $10.07
- Average True Range (ATR)
- WKC 0.51
- BCRX 0.34
- MACD
- WKC -0.07
- BCRX -0.18
- Stochastic Oscillator
- WKC 68.67
- BCRX 8.10
About WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.